Gene-editing medicines developer Intellia Therapeutics is paying $45 million up front to acquire Rewrite Therapeutics. The startup's technology brings Intellia another tool for its genetic medicines toolbox, one that could enable even more precise edits.
At a time when a large portion of healthcare practitioner interactions have switched to digital, it's clear that life science companies need to transform their approach to be much more collaborative in the way they work with healthcare professionals.
A new survey from Reuters Events in collaboration with Microsoft and Exeevo, Medical-commercial collaborating to win in the digital era, offers an inside look at the trends and challenges with which life science professionals have to contend, and how they are responding and explores new strategies and tactics for how these companies are working with healthcare providers and adapting themselves to improve the patient experience in healthcare.
We are extending our INVEST 2022 Pitch Perfect deadline to Feb 11, 11:59 p.m. ET to allow interested startups to apply to the 4 tracks - PharmaTech, Diagnostics 2.0, Care Coordination and Value-Based Care, and Remote Patient Monitoring and Smart Devices. Slots are going fast so we encourage all startups - particularly those interested to apply in the PharmaTech and Diagnostics tracks to apply immediately. Selected startups will get to pitch LIVE on stage in front of VC judges. Here's the agenda for the INVEST conference.
Leverage the Knowledge Hub on MedCity News to elevate thought leadership and awareness and generate leads for your sales team – ONLY paying for qualified leads..
The oldest news in the world still seems to be that we have a dearth of cybersecurity talent – now for the fifth consecutive year. In its latest annual report, The Life and Times of Cybersecurity Professionals 2021, ISSA reveals several reasons for the shortage.
By Hugo Manassei Thursday, February 3, 2022 6:47 PM
Prioritizing convenience while also maintaining valuable relationships between patients and healthcare teams is at the heart of the digital transformation of healthcare, and will help convert the trend of virtual care into something altogether more sophisticated: "distributed care," where everything can be done digitally — and much of it at home.
By Michael Schroeder Thursday, February 3, 2022 5:24 PM
Wells Fargo Strategic Capital led the Series B funding round. Concerto also announced Thursday that it has acquired Crown Health, a home-based primary care practice serving the Pacific Northwest.
By Julie Appleby, Kaiser Health News Thursday, February 3, 2022 4:35 PM
Therapists say their professional codes of ethics already require disclosure to patients of per-visit costs. Requiring diagnostic billing codes in the estimate before even seeing a patient — as they interpret the rule — is unethical, they argue, and tallying up what might be weeks or even months of treatment costs could keep some patients from undergoing care.
By Frank Vinluan Thursday, February 3, 2022 4:30 PM
Gene-editing medicines developer Intellia Therapeutics is paying $45 million up front to acquire Rewrite Therapeutics. The startup's technology brings Intellia another tool for its genetic medicines toolbox, one that could enable even more precise edits.
By Frank Vinluan Thursday, February 3, 2022 12:59 PM
Dewpoint is developing drugs targeting biomolecular condensates, tiny droplets in cells that contain proteins and nucleic acids. Dysfunction of these organelles can play a role in a wide range of diseases, including neurodegenerative disorders and cardiovascular disease.
By Andrew Lacy Thursday, February 3, 2022 12:46 PM
It wasn't until I saw a before-and-after scan of my spine and neck that I realized just how much damage I'd been doing to myself by continuously slumping over my computer during the pandemic.
No comments